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Abstract
Background: Population ageing over the ﬁrst half of this century is likely to lead to dramatic increases in the
prevalence of dementia. This will aﬀect all regions of the world, but particularly developing regions. Dementia
projections have been used extensively to support policy. It is therefore important these projections are as accurate as
possible.
Discussion: In this paper we provide a commentary on studies projecting the future prevalence of dementia for the
world or for individual continents. We identify some important limitations of the methods used in published
projections and provide recommendations to improve the accuracy of future projections, and allow for the checking
of the accuracy of the predictions.
Summary: Accurate projections of dementia incidence, at both the global and local level, are essential for healthcare
planners.
Background
The prevalence of dementia is a major concern for future
global public health [1]. Population ageing, driven by
greater life-expectancy and low fertility, will result in a
dramatic growth in the older population in all regions. By
the middle of this century around 1 in 5 of the estimated
9 billion world population are expected to be aged over
60-years, compared to around 1 in 10 in 2000 [2]. Since
dementia incidence increases exponentially with age [3],
the likely future number of dementia cases and associ-
ated burden on the healthcare system is of considerable
concern to healthcare planners [4,5].
So that our evaluation is evidence-based we conducted
a scoping exercise to identify studies, published in peer
reviewed journals, presenting projections concerning the
world as a whole or for individual continents. (Details of
these studies, along with the search strategy and selection
criteria, are given in the online Additional ﬁle 1) This lit-
erature search identiﬁed a large and growing number of
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dementia projections. Unequivocally, the projections indi-
cated that, irrespective of region, the projected number of
cases of dementia is predicted to rise dramatically during
the ﬁrst half of this century (Figure 1). Furthermore, due
to the larger expected gains in life expectancy for develop-
ing countries, steeper increases in the estimated number
of cases of dementia in the regions consisting of Latin
America and the Caribbean, and Africa, Asia and Oceania
compared to Europe and North America [6,7].
These estimates provide a gloomy outlook. However, it
is not clear to what extent these projections compare with
current prevalence estimates. For example, although pro-
jections suggest a dramatic increase in dementia, there is
evidence that the prevalence over the past 20 years has
remained stable or even reduced [8-10]. Dementia pro-
jections make several important assumptions about the
stability of dementia prevalence and incidence over time
and across regions that are likely to impact on accu-
racy of the projection. These assumptions further suppose
that dementia risk factors will also remain stable, which
is highly unlikely. Projections need to account for likely
changes in the future prevalence of dementia risk factors,
as well as uncertainty regarding their true causal link with
dementia. In this paper we describe the limitations of the
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Figure 1 Dementia projections. Lines with circle markers indicate dementia; lines with square markers indicate Alzheimer’s disease; dashed lines
indicate projection is for US only. The ﬁgure shows projections from previously published projections by continent.
methods used by the dementia projection studies and oﬀer
recommendations that will help to increase the validity
and reliability of future projections.
Discussion
The dementia projections identiﬁed used two diﬀer-
ent methodologies (see Additional ﬁle 1): extrapolations
[7,11,12] and macro-simulations [3,13-15]. Extrapolations
estimate the future number of cases of dementia by simply
multiplying the expected number people within speciﬁc
age (and sometimes sex) strata from an existing popula-
tion projection by an estimate of the current prevalence
of dementia within the same strata. Providing a simplistic
example, the UN estimates that there will be 1 billion peo-
ple aged 65 and over in 2050 [2], if we assume the current
prevalence in over 65’s is 7% thenwewould extrapolate the
number of cases of dementia in the over 65’s in 2050 to be
70 million (1, 000, 000, 000 × .07 = 70, 000, 000). Macro-
simulations apply a slightly diﬀerent approach. Current
population estimates stratiﬁed by age (and possibly other
factors, such as sex) are used as the baseline popula-
tion, and the current number of dementia cases calculated
using existing prevalence estimates. Then, using transition
probabilities from a multistate illness-death model, the
number of incident cases of dementia and deaths within
a speciﬁed time interval is calculated. The model is then
aged forward by the speciﬁed time interval, accounting
for the transitions to dementia or death, and updated
using numbers for the youngest age group from exist-
ing population projections. The number of incident cases
of dementia and deaths within the next interval is then
calculated. This is run iteratively up to the end year.
The assumptions underlying these approaches are sum-
marised in Table 1 and the main advantages and disad-
vantages of the methods along with a third method, micro
simulation, is presented in Table 2. The limiting impact
of the assumptions underlying extrapolations and macro
simulations on projection accuracy are now discussed.
Table 1 Projectionmethod assumptions
Extrapolation Cell-basedmacro-simulation
Constant prevalence over time Constant incidence over time
Constant prevalence between regions Constant incidence between
regions
Equal mortality risk Constant diﬀerence in mortality
risk
Constant rate of progression Rate of progression stable over
time
Risk factors stable over time Risk factors stable over time
Risk factors stable between regions Risk factors stable between
regions
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Table 2 Advantages and disadvantages of projectionmethods
Extrapolation Macro simulation Micro simulation
Complexity Simple Not overly complex Complex
Account for excess mortality in dementia No Yes Yes
Account for changes in incidence or prevalence Yes Yes Yes
Account for changes in progression No Yes Yes
Directly account for changes in risk factors No No Yes
Allows identiﬁcation of distributional characteristics of systems No No Yes
Mortality diﬀerential
The extrapolation method makes several strong assump-
tions. Perhaps the least feasible is that mortality rates are
assumed to be equal in healthy and demented groups.
A considerable body of research has highlighted the
increased mortality associated with dementia [16]. Failure
to account for this is likely to upwardly bias projections.
Cell-based macro-simulations that assume transition
from a healthy state to dementia and from the healthy and
demented states to death explicitly account for the mor-
tality diﬀerential. Some studies additionally include tran-
sition from early to late-stage dementia [6,15], accounting
for the increased mortality risk in more severe disease.
Stability of risk factors
Both extrapolations and multi-state models make strong
assumptions concerning the constancy of certain factors
over time. For extrapolations, the assumption is that the
relative prevalence does not change with time, other than
as a result of changes in demographic factors that are used
as strata in the calculations. In contrast, inputs to multi-
state models (e.g. incidence, progression and mortality),
although typically assumed to be constant over time in the
baseline model, can be modiﬁed to reﬂect diﬀerent future
scenarios. However, other factors that are not inputs to the
models are implicitly assumed constant over time, such as
the prevalence of risk factors. It is important to note that
the aim of a projection is not necessarily to forecast the
future but to highlight the extent of the problem if risk fac-
tor trends remain stable. However, examining the impact
of changing patterns of risk factors is key since it identiﬁes
targets most likely to lead to eﬀective intervention.
Several studies employing cell-based macro-simulations
examined hypothetical scenarios of delayed incidence or
progression of dementia [3,15,17]. The relatively crude
analyses conducted assume a step change in rates of inci-
dence or progression at a speciﬁc time. Miracle cures are
often heralded following scientiﬁc breakthroughs in our
understanding of pathology but seldom are realised. In
actuality changes in rates of incidence and progression
of dementia are more likely to come from a combination
of factors, with substantial contribution from risk fac-
tor modiﬁcation [18,19]. For example, a recent study
suggested population attributable risk relating to modiﬁ-
able risk factors — such as diabetes, mid-life hyperten-
sion, obesity, smoking, physical or cognitive inactivity and
depression — to be in the order of 50% [18]. Although
this estimate is likely to be considerably inﬂated due to
the assumption of independence of risk factors in its cal-
culation, the contribution of behavioural factors to both
the incidence and progression of dementia is clearly not
insigniﬁcant. This raises the issue that modiﬁcation of
behavioural risk factors may impact on incidence and pro-
gression gradually and over an extended period of time.
This issue is ignored by all current dementia projections.
Furthermore, it is unclear whether changes in the treat-
ment of other conditions may impact on the prevalence
of dementia. For example, increased post-stroke survival
may lead to increases in dementia incidence [20,21] but
there is also some evidence suggesting statins may have
some preventative implications for dementia [22]. It is
clear that the accuracy of projections that do not address
these issues is limited.
A related issue is the timing of the presence of risk fac-
tors. Treves and Korczyn highlight the importance of con-
sidering the age at which exposure to risk factors begins
since their eﬀect “may depend upon the age at which they
act and their interaction with other factors or concomitant
conditions, which underlines the importance of stratiﬁed
and multivariate analyses by period of exposure” [23]. For
example, mid-life diabetes and hypertension aremore pre-
dictive of development of AD than the presence of these
conditions in later periods [18]. There is only limited util-
ity in modelling the impact of late-life hypertension if
mid-life hypertension is a more important predictor.
Future analyses must be based on the assessment of
more plausible scenarios regarding changes in patterns
of risk factors, and their inﬂuence on both the incidence
of dementia and its progression over time along with the
examination of life-course inﬂuences through age, period
and cohort eﬀects.
Generalisibility
Assumptions of constancy also apply across countries.
Risk factor proﬁles are likely to diﬀer across countries
at the present time but are also likely to follow diﬀerent
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future trends and therefore generalising estimates of
prevalence and incidence assuming constancy over time
and over countries may not be the best possible approach.
This is emphasised by the studies projecting future preva-
lence of dementia in Latin American, African and Asian
populations [6,7]. The estimates from Brookmeyer et
al. were solely based on the pooled incidence estimates
of US studies, which tend to be higher than for other
regions [24]. The resultant projections for Asia, Africa and
Oceania with respect to AD were higher than those for all
dementias projected by Ferri et al. who allowed prevalence
to vary across countries using a Delphi consensus study.
The Delphi method attempts to account for demographic
diﬀerences between regions by developing region spe-
ciﬁc age and sex stratiﬁed prevalence estimates guided by
expert panel consensus. Nevertheless, the Delphi method
still fails to systematically account for likely future changes
in the demographic structure that may have a bearing on
future dementia prevalence.
A further factor impacting on generalisibility is that
studies publishing projections typically rely on data con-
cerning the prevalence and incidence drawn from a range
of sources. For example, Brookmeyer et al. [3] pooled
prevalence rates across four US studies, whereas Wancata
et al. [11] pooled estimates from multiple meta-analyses.
The use of summary data has the advantage that it may
more closely generalise to the population of interest — as
long as estimates are pooled across homogenous samples.
Individual data however allow for the building of more
complex models that can account more appropriately for
changes in underlying risk factors [25].
Recommendations for future projections
Recent developments inmultistate modelling allow for the
extension to the illness-death models employed in macro-
simulation projections to more appropriately account for
issues such as the timing of dementia onset and poten-
tial misdiagnosis [26]. Currently illness-death models
employed in macro-simulation studies use a discrete-time
framework. Using a continuous-time framework allows
for a more ﬁne grained examination of the changing haz-
ard for development of dementia or death over time that
will lead tomore accurate estimates of dementia incidence
in light of underlying risk factors. Another development
is the ability to handle potential misclassiﬁcation within
the model thus accounting for potential misdiagnosis of
dementia [27].
Micro-simulation also provides an opportunity to
further develop existing dementia projection models
(Table 2). The use of micro-simulation allows for dynamic
modelling of ageing and health estimation enabling more
robust conclusions to be drawn with regard to the inﬂu-
ence of changing patterns of underlying risk factors and
the impact of policy changes. For example, Canadas
Population Health Model (POHEM) uses individual level
data concerning socio-demographic, behavioural and
biomedical factors to simulate morbidity and mortality
for various diseases and is used to evaluate competing
health care scenarios for speciﬁc diseases [28]. A disad-
vantage of micro-simulation is that the method can be
rather complicated to implement.
Summary
In conclusion, population ageing is likely to lead to dra-
matic increases in the prevalence of dementia in future
years. Providing accurate estimates of the future number
of cases of dementia is essential for healthcare planners.
Current estimates often extrapolate age-speciﬁc preva-
lence estimates to existing population projections or use
macro-simulations based on age-speciﬁc dementia inci-
dence. While such projections are useful in highlighting
the scale of the problem were risk factors to remain sta-
ble over time, this is clearly an untenable assumption. The
development of sophisticated projection models that not
only account for the incidence, progression and excess-
mortality of dementia but also allow for detailed examina-
tion of the inﬂuence of changing patterns of risk factors on
future prevalence is essential. This will enable researchers
to target modiﬁable risk factors identiﬁed by epidemio-
logical studies where intervention is most likely to delay
dementia onset, thus reducing overall prevalence in future
populations. Complex interrelationships and uncertain-
ties about the causal status of dementia risk factors pose
a problem for multi-state models. However, such mod-
els allow scenarios where changes in the prevalence and
incidence of risk factors, or the strength of their causal
association with dementia, may be compared.
We do not suggest the outright dismissal of pro-
jections based on extrapolations and macro-simulation
methods but recommend an increased investment in
micro-simulation as a complement to existing projec-
tions. Applying estimates from a single source that is
appropriate to the population of interest using both a
macro and micro-simulation framework will allow for
detailed examination of uncertainty around the projec-
tions and the impact of changes in underlying patterns of
risk factors.
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